glp 1 agonist clinical trials 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿 𝗔𝗴𝗼𝗻𝗶𝘀𝘁𝘀 𝗼𝗻 𝗚𝗹𝘆𝗰𝗮𝘁𝗲𝗱 𝗛𝗲𝗺𝗼𝗴𝗹𝗼𝗯𝗶𝗻 𝗟𝗲𝘃𝗲𝗹𝘀 ⁣ ⁣ Randomized, placebo-controlled of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong GLP-1 receptor agonists show promise

[DOI] [PubMed] [Google Scholar] 583.De Marinis Y.Z., Salehi A., Ward C.E., Zhang Q., Abdulkader F., Bengtsson M

Lee MC, Tu YT, Lee CC, Tsai SC, Hsu HY, Tsai TY, et al

Berberine is a plant compound thats been shown to activate the same GLP-1 pathways as prescription weight loss medications, supporting appetite control, blood sugar regulation, and fat metabolism

These cardiovascular advantages have made GLP-1 medications a preferred choice for type 2 diabetes patients with established cardiovascular disease

Weight-loss medications like GLP-1 are changing lives, but they also bring real challenges: Appetite loss Protein deficiency Nausea & bloating Muscle loss Fatigue Nutritional imbalance In the U.S., an entire industry has already formed around supporting these patients

Blood Pressure and Lipids Both medications produce similar improvements in cardiovascular risk factors: Blood pressure: Both typically reduce systolic BP by 3-6 mmHg Effects are similar between medications Lipids: Both reduce triglycerides Modest effects on LDL cholesterol Similar lipid improvements Metabolic Comparison Cost and Insurance Cost considerations may influence medication choice for some patients